News

Bridget Duffy, MD, Enhances Vital Board with Expertise

Bridget Duffy, MD, Enhances Vital Board with Expertise

Bridget Duffy, MD, Joins Vital's Board of Directors

Vital, an AI-powered patient experience company, proudly announces the addition of Dr. Bridget Duffy to its board of directors. With a strong focus on enhancing the patient experience, Dr. Duffy has established herself as a leader in healthcare through her innovative approach to human-centered care.

Transformative Background in Healthcare

Dr. Duffy is widely recognized as the first chief experience officer (CXO) in healthcare and has a remarkable track record of transforming patient experiences across systems. Previously serving as the CXO at the Cleveland Clinic, she emphasized that empathy and connection are as vital to healthcare as clinical excellence. Her work has been instrumental in shaping healthcare practices that prioritize human interactions.

Innovative Ventures

Through her entrepreneurial spirit, Dr. Duffy co-founded ExperiaHealth, a company dedicated to restoring humanity in healthcare. Under her leadership, it quickly gained traction and was acquired by Vocera Communications, where she served as chief medical officer until its acquisition by Stryker in 2022. This extensive background in healthcare leadership uniquely positions her to make significant contributions to Vital.

Visionary Leadership at Vital

CEO Aaron Patzer expressed confidence in Dr. Duffy's impact: "Her expertise in clinician engagement and system transformation aligns perfectly with our mission to simplify hospital workflows and enhance patient outcomes. We're thrilled to welcome her to our team." Vital is dedicated to utilizing technology that not only facilitates communication but also reinforces compassionate care.

Enhancing Patient Experience

Vital harnesses advanced technology to provide timely updates and personalized information during patients' hospital visits, creating an intuitive interface without complicating the user experience. With a commitment to improving operational efficiency, Vital’s solutions are leading to a major increase in patient satisfaction scores and reducing emergency department length-of-stays.

Future of Digital Health

Dr. Duffy has a clear vision for the future of healthcare, stating, "Vital is in a unique position to redefine hospital communication with patients, minimizing clinician burnout while providing personalized care. I am excited to contribute to this great team as we reshape digital health." Her expertise and passion underscore Vital's dedication to an empathetic approach to healthcare delivery.

Commitment to Workforce Well-being

In addition to her new role, Dr. Duffy co-founded the CEO Coalition, a nationwide initiative advocating for the well-being and safety of healthcare workers. Her contributions to this important movement highlight her deep commitment to improving not just patient care but also the environments in which healthcare professionals operate.

Exciting Executive Promotions

Alongside Dr. Duffy's appointment, Vital is also excited to announce two executive promotions. Dr. Nicholas Sterling, formerly the director of clinical innovation and research, has advanced to become the chief medical informatics officer (CMIO). Dr. Michael Rogozinski has also stepped up as the new chief nursing officer (CNO), bringing fresh perspectives to leadership.

About Vital

Vital is an AI-driven company on a mission to transform the patient journey. By providing real-time insights, predictive wait times, and user-friendly communication, Vital ensures that patients are informed and feel valued throughout their experience. Recognized by KLAS for excellence in patient experience, Vital continuously achieves remarkable outcomes and pushes the boundaries of healthcare innovation.

Frequently Asked Questions

Who is Bridget Duffy, MD?

Bridget Duffy, MD, is an expert in humanizing the patient experience and previously served as the first CXO at the Cleveland Clinic.

What is Vital's mission?

Vital aims to improve the patient journey by using innovative technology to enhance communication and operational efficiency in healthcare.

What impact will Dr. Duffy have at Vital?

Dr. Duffy's extensive experience in health systems and leadership will enhance Vital's mission of simplifying hospital workflows and improving patient outcomes.

What are some recent changes at Vital?

Vital appointed Bridget Duffy to its board and also promoted Nicholas Sterling to CMIO and Michael Rogozinski to CNO.

How does Vital's technology work?

Vital leverages intuitive technology to provide real-time updates and education to patients without requiring app downloads, enhancing their hospital experience.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Network API Market by 2030

Updated Category News Views 125

Network API Market Overview As technology evolves, the demand for Network APIs is accelerating, and projections show the market will grow from USD 1.96 billion to an impressive USD 6.13 billion by 2030, reflecting a compound annual growth rate (CAGR) of 25.7% during the forecast period. This surge signifies a shift in how businesses leverage APIs to enhance connectivity...

Continue Reading
Quebec City Real Estate Market Sees Strong Activity Surge

Updated Category News Views 179

Quebec City Real Estate Market Activity in August As summer comes to a close, the residential real estate market in Quebec City is experiencing notable activity, achieving the second highest sales levels in 25 years for this month. This trend highlights the remarkable resilience and ongoing demand in a market that continues to change. Sales Data Overview In August, the...

Continue Reading
Understanding Market Trends: Income Strategies with IQQQ ETF

Updated Category News Views 151

Navigating the Current Tech Market Dynamics This year, the Nasdaq Composite index has outperformed other major indices, showing a solid increase of more than 21%. This surge in technology stocks has, however, been volatile, with the index recently experiencing a dip of roughly 2%. Concerns around a potential bubble in artificial intelligence have contributed to this...

Continue Reading
Boussard & Gavaudan Holding Limited: Latest NAV Update

Updated Category News Views 272

Boussard & Gavaudan Holding Limited Overview Boussard & Gavaudan Holding Limited is a well-known closed-ended investment company recognized within the finance industry for its effective management strategies. This article provides recent updates on the company's net asset value (NAV) and market activities. Estimated NAV Information The Directors of Boussard & Gavaudan...

Continue Reading
Currency Insights: Dollar and Yen Dynamics Amid Changes

Updated Category News Views 153

Current Trends in Currency Markets The US dollar is maintaining its strength as holiday trading continues with low volumes, while US Treasury yields are gradually rising. Although the dollar remains resilient against various currencies, it has shown some weakness against the Japanese yen and Canadian dollar lately. Markets are keenly observing the impact of potential...

Continue Reading